Pathkey.Ai Ltd Completes Chipforge Acquisition to Enter Custom Chip Design
Pathkey completes Chipforge acquisition, extending its AI architecture into semiconductor design
Pathkey.AI (ASX: PKY) has settled and completed the acquisition of 100% of Chipforge Pte Ltd, a Singapore-domiciled artificial intelligence semiconductor design company.
The transaction extends Pathkey’s agent-based AI architecture beyond clinical trial design, where its existing TrialKey platform operates, into the global market for custom chip development. For investors, the move diversifies the Company’s platform portfolio into a high-growth, talent-constrained sector.
When big ASX news breaks, our subscribers know first
The deal terms: what Pathkey paid for Chipforge
The acquisition was structured as scrip consideration rather than cash. Pathkey issued 560,000,000 fully paid ordinary shares plus 150,000,000 performance rights, each convertible into shares on a one-for-one basis subject to the vesting milestones set out in the Company’s ASX announcement dated 29 April 2026.
The original binding agreement, announced in late April 2026, outlined a dual-market AI strategy in which Pathkey would fund the acquisition entirely from existing cash reserves without any capital raise, with total planned expenditure across both platforms reaching $4,100,000 over the following 12 months.
Under the terms of the deal, Chipforge is entitled to nominate one representative for appointment as a non-executive director within 12 months of completion, being 22 June 2027. This right had not been exercised as at the date of the announcement.
| Deal Component | Detail |
|---|---|
| Target acquired | 100% of Chipforge Pte Ltd |
| Ordinary shares issued | 560,000,000 |
| Performance rights | 150,000,000 (1-for-1, milestone-vesting) |
| Director nomination right | 1 non-executive director by 22 June 2027 (unexercised) |
What Chipforge does and why it matters
Designing a custom semiconductor is a slow and expensive undertaking. The process currently takes 12 to 24 months and costs millions of dollars, creating a significant barrier for organisations that need bespoke chips.
Chipforge is developing an Agentic AI platform that translates high-level design intent into “verified, synthesisable hardware code”, compressing those long development cycles. In practice, the workflow generates the hardware design code, builds and runs the tests required to verify it, then progresses the design through synthesis and implementation on Field Programmable Gate Array (FPGA) hardware. The roadmap extends toward full Application-Specific Integrated Circuit (ASIC) development.
The platform is built on three core technology pillars:
-
Agent-Based AI Architecture
-
Large-Language-Model functionality
-
Closed-Loop reflection methodology
Chipforge is positioned to serve a range of demanding end markets, including:
-
Defence
-
Aerospace
-
Critical infrastructure
-
Research institutions
-
Developers of custom chips for AI, edge computing and embedded systems
For investors, the acquisition places Pathkey within the growing global demand for sovereign, locally controlled chip design, a strategically sensitive area where speed and cost reduction carry commercial weight.
The exclusive worldwide licence underpinning the platform
Chipforge’s core technology is not owned outright. It is licensed from Ntuitive Pte Ltd, associated with Nanyang Technological University in Singapore, under an “exclusive, worldwide licence (with a right to sub-license)”, referred to as the Ntuitive Licence Agreement.
The agreement is subject to minimum development, commercialisation and revenue commitments, along with the payment of annual licence fees. The arrangement gives Pathkey access to intellectual property developed at a leading global research university, which management frames as a defensible foundation for the platform.
Strategic rationale: one architecture, two platforms
The strategic logic centres on a shared technical foundation. Both the Chipforge platform and the existing TrialKey platform are built on agent-based AI architecture that combines large-language-model functionality with neuro-symbolic reasoning to solve complex design-optimisation problems.
The Company expects material cross-platform synergies, with know-how, data-pipeline methodology and engineering advances developed for one platform being directly applicable to the other. Pathkey has confirmed it intends to continue developing both the TrialKey and Chipforge platforms.
For investors, the deal extends the Company’s AI capabilities from clinical development into semiconductor design and engineering, advancing its stated ambition to build a scalable, defensible AI ecosystem.
CEO Commentary
“This is a pivotal moment for PKY. Chipforge applies the same architecture that underpins our TrialKey platform to one of the most expensive and talent-constrained processes in modern technology, being the design and verification of custom semiconductors. Pathkey has gained not only the Chipforge technology but an exclusive, worldwide licence to intellectual property developed at one of the World’s leading research universities. We look forward to demonstrating the platform’s capability as we rapidly move towards commercialisation, and to extending Pathkey’s AI capabilities into the growing global demand for sovereign, locally controlled chip design.” said Andrew Farnsworth, Chief Executive Officer.
The next major ASX story will hit our subscribers first
What comes next for Pathkey
Management has signalled a focus on moving rapidly toward commercialisation of the Chipforge platform. The technology roadmap runs from current FPGA implementation toward full ASIC development over time.
The director nomination window remains open until 22 June 2027. Further detail on Chipforge, the Ntuitive Licence Agreement, the post-completion activities and the strategic rationale for the acquisition is set out in the Company’s ASX announcement dated 29 April 2026.
Chair Commentary
“The completion of the Acquisition is a defining step in Pathkey’s strategy of assembling complementary, agentic AI platforms. It strengthens our position, broadens our capability base, and advances the Company’s ambition to build a scalable, defensible AI ecosystem. The Board is pleased to have received strong shareholder support for this transaction and looks forward to driving meaningful value as we integrate Chipforge and execute on our growth objectives.” said Shannon Robinson, Chair.
Don’t Miss the Next ASX Tech Breakout
Big News Blast delivers FREE breaking ASX tech and AI news directly to your inbox within minutes of release, complete with in-depth analysis already done for you. Over 20,000 subscribers are already getting the edge. Click the “Free Alerts” button at Big News Blast to make sure the next market-moving announcement lands with you before the market moves.